Die Rolle des Tumormikromilieus bei der T-Zell-Erschöpfung und Immunität von malignen ZNS Tumoren

Glioblastomas are malignant tumors of the central nervous system which lead to death within 1-2 years. Promising immunotherapeutic approaches failed to improve survival in glioblastomas. Although the reasons are not completely understood yet, it is assumed that the tumor environment is a barrier for immune cells. In the funded research project, we aim is to investigate the mechanism by which the inactivation of the immune system occurs, which cells are engaged in this process and how this inactivation can be prevented.

Enhancement of antitumor immunogenecity in pancreatic cancer via intrapancreatic transplantation of tumor lysate-pulsed dendritic cells

Pancreatic cancer (PCa) is characterized by its highly immunosuppressive microenvironment and resistance to immune-based therapies. Recent studies demonstrated that dendritic cells (DC) may potentiate the effect of immune checkpoint inhibitors (ICI) in many solid malignancies. In this context, tertiary lymphoid structures (TLS) represent privileged sites for presentation of tumor antigens by DCs and subsequent activation of T cell and B cell responses.

The impact of peripheral inflammation on the human brain’s immune response and its role in Alzheimer’s disease

Many brain diseases show an activation of the immune system and this immune response can contribute to disease severity. The brain’s immune response can be altered by inflammatory events outside of the brain, and our previous work demonstrated that this leads to long-lasting changes in the immune response, which in turn alters the progression of Alzheimer’s disease pathology in animal models. Thus, the brain’s immune cells have an immunological memory function, which can impact on brain diseases that develop much later in life.

Deciphering acute kidney injury

Acute kidney injury (AKI) remains a frequent complication of severe disease. Despite progress in supportive care, the overall mortality and long-term consequences of this complication have not changed significantly. Although complex genetic models and cell lineage tracking have identified subsets of cells that play a central role during the recovery of renal function, the processes that occur immediately after an injury remain unknown because it is virtually impossible to assess these events in mammalian models.

EKFS verleiht erstmalig Publikationspreise an drei von ihr geförderte Nachwuchswissenschaftler

Der Preis ist mit einem persönlichen Preisgeld in Höhe von jeweils 10.000 Euro dotiert.

Erstmalig vergibt die Stiftung eine persönliche, nicht projektbezogene, Auszeichnung an junge Nachwuchswissenschaftler als Würdigung einer besonders wichtigen medizinischen Entdeckung, die im Jahr 2019 veröffentlicht wurde. Sie würdigt damit eine außergewöhnliche Leistung am Beginn der wissenschaftlichen Laufbahn der jungen Medizinforscher.